留言板

尊敬的读者、作者、审稿人, 关于本刊的投稿、审稿、编辑和出版的任何问题, 您可以本页添加留言。我们将尽快给您答复。谢谢您的支持!

姓名
邮箱
手机号码
标题
留言内容
验证码

维生素D在孤独症谱系障碍发病机制中的作用研究进展

刘姿镃 金宇

刘姿镃, 金宇. 维生素D在孤独症谱系障碍发病机制中的作用研究进展[J]. 中国学校卫生, 2025, 46(2): 300-304. doi: 10.16835/j.cnki.1000-9817.2025054
引用本文: 刘姿镃, 金宇. 维生素D在孤独症谱系障碍发病机制中的作用研究进展[J]. 中国学校卫生, 2025, 46(2): 300-304. doi: 10.16835/j.cnki.1000-9817.2025054
LIU Zizi, JIN Yu. Research progress on the pathogenesis of vitamin D in autism spectrum disorder[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2025, 46(2): 300-304. doi: 10.16835/j.cnki.1000-9817.2025054
Citation: LIU Zizi, JIN Yu. Research progress on the pathogenesis of vitamin D in autism spectrum disorder[J]. CHINESE JOURNAL OF SCHOOL HEALTH, 2025, 46(2): 300-304. doi: 10.16835/j.cnki.1000-9817.2025054

维生素D在孤独症谱系障碍发病机制中的作用研究进展

doi: 10.16835/j.cnki.1000-9817.2025054
基金项目: 

广东省自然科学基金项目 2023A1515012442

详细信息
    作者简介:

    刘姿镃(1998-),女,云南省人,在读硕士,主要研究方向为儿童孤独症谱系障碍

    通讯作者:

    金宇,E-mail: jinyu@mail.sysu.edu.cn

  • 利益冲突声明  所有作者声明无利益冲突。
  • 中图分类号: R591.44 R748 B844.1

Research progress on the pathogenesis of vitamin D in autism spectrum disorder

  • 摘要: 为从新的视角探讨孤独症谱系障碍(ASD)的发病机制,研究通过文献整理发现维生素D(Vit D)可能通过抑制儿童早期大脑过度生长、调节中枢神经系统代谢,调节免疫、抗炎及影响基因组稳定对ASD的发生发展产生重要作用。对ASD人群进行Vit D补充发现可改善相关症状,然而至今Vit D对ASD的作用机制尚不明确,Vit D治疗对ASD的症状改善结果也因样本量、检测方法、剂量及混杂因素等原因尚存争议。未来可通过进一步多中心、大样本的随机对照试验和Vit D缺乏的ASD动物模型探索Vit D在ASD发病和治疗中的具体作用,为ASD早发现、早干预、早治疗提供可靠的证据。
    1)  利益冲突声明  所有作者声明无利益冲突。
  • [1] LORD C, ELSABBAGH M, BAIRD G, et al. Autism spectrum disorder[J]. Lancet, 2018, 392(10146): 508-520. doi: 10.1016/S0140-6736(18)31129-2
    [2] Global Burden of Disease Study 2021 Autism Spectrum Collaborators. The global epidemiology and health burden of the autism spectrum: findings from the Global Burden of Disease Study 2021[J]. Lancet Psychiatry, 2025, 12(2): 111-121. doi: 10.1016/S2215-0366(24)00363-8
    [3] JIANG X, CHEN X, SU J, et al. Prevalence of autism spectrum disorder in mainland China over the past 6 years: a systematic review and Meta-analysis[J]. BMC Psychiatry, 2024, 24(1): 404. doi: 10.1186/s12888-024-05729-9
    [4] HARRIS J. Leo kanner and autism: a 75-year perspective[J]. Int Rev Psychiatry, 2018, 30(1): 3-17. doi: 10.1080/09540261.2018.1455646
    [5] MASINI E, LOI E, VEGA-BENEDETTI A F, et al. An overview of the main genetic, epigenetic and environmental factors involved in autism spectrum disorder focusing on synaptic activity[J]. Int J Mol Sci, 2020, 21(21): 8290. doi: 10.3390/ijms21218290
    [6] ABDELKADER A, ALRADINI F, ALOSAIMI A, et al. Unveiling the influences of prenatal and maternal factors on the journey of an autistic child[J]. Front Psychiatry, 2024, 15: 1467821. doi: 10.3389/fpsyt.2024.1467821
    [7] PERETTI S, MARIANO M, MAZZOCCHETTI C, et al. Diet: the keystone of autism spectrum disorder?[J]. Nutr Neurosci, 2019, 22(12): 825-839. doi: 10.1080/1028415X.2018.1464819
    [8] ALTUN H, KURUTAŞ E B, ŞAHIN N, et al. The levels of vitamin D, vitamin D receptor, homocysteine and complex B vitamin in children with autism spectrum disorders[J]. Clin Psychopharmacol Neurosci, 2018, 16(4): 383-390. doi: 10.9758/cpn.2018.16.4.383
    [9] GARCÍA-SERNA A M, MORALES E. Neurodevelopmental effects of prenatal vitamin D in humans: systematic review and Meta-analysis[J]. Mol Psychiatry, 2020, 25(10): 2468-2481. doi: 10.1038/s41380-019-0357-9
    [10] BROUWER-BROLSMA E M, VRIJKOTTE T G M, FESKENS E J M. Maternal vitamin D concentrations are associated with faster childhood reaction time and response speed, but not with motor fluency and flexibility, at the age of 5-6 years: the Amsterdam born children and their development (ABCD) study[J]. Br J Nutr, 2018, 120(3): 345-352. doi: 10.1017/S0007114518001319
    [11] CHIEN M C, HUANG C Y, WANG J H, et al. Effects of vitamin D in pregnancy on maternal and offspring health-related outcomes: an umbrella review of systematic review and Meta-analyses[J]. Nutr Diabetes, 2024, 14(1): 35. doi: 10.1038/s41387-024-00296-0
    [12] SASS L, VINDING R K, STOKHOLM J, et al. High-dose vitamin D supplementation in pregnancy and neurodevelopment in childhood: a prespecified secondary analysis of a randomized clinical trial[J]. JAMA Netw Open, 2020, 3(12): e2026018. doi: 10.1001/jamanetworkopen.2020.26018
    [13] ARASTOO A A, KHOJASTEHKIA H, RAHIMI Z, et al. Evaluation of serum 25-hydroxy vitamin D levels in children with autism spectrum disorder[J]. Ital J Pediatr, 2018, 44(1): 150. doi: 10.1186/s13052-018-0587-5
    [14] ZHANG M, WU Y, LU Z, et al. Effects of vitamin D supplementation on children with autism spectrum disorder: a systematic review and Meta-analysis[J]. Clin Psychopharmacol Neurosci, 2023, 21(2): 240-251. doi: 10.9758/cpn.2023.21.2.240
    [15] CUI J, ZHAI Z, WANG S, et al. The role and impact of abnormal vitamin levels in autism spectrum disorders[J]. Food Funct, 2024, 15(3): 1099-1115. doi: 10.1039/D3FO03735E
    [16] YE X, ZHOU Q, REN P, et al. The synaptic and circuit functions of vitamin D in neurodevelopment disorders[J]. Neuropsychiatr Dis Treat, 2023, 19: 1515-1530. doi: 10.2147/NDT.S407731
    [17] SAILIKE B, ONZHANOVA Z, AKBAY B, et al. Vitamin D in central nervous system: implications for neurological disorders[J]. Int J Mol Sci, 2024, 25(14): 7809. doi: 10.3390/ijms25147809
    [18] LO C S, KIANG K M, LEUNG G K. Anti-tumor effects of vitamin D in glioblastoma: mechanism and therapeutic implications[J]. Lab Invest, 2022, 102(2): 118-125. doi: 10.1038/s41374-021-00673-8
    [19] RAHDAR M, DAVOUDI S, DEHGHAN S, et al. Reversal of electrophysiological and behavioral deficits mediated by 5-HT7 receptor upregulation following LP-211 treatment in an autistic-like rat model induced by prenatal valproic acid exposure[J]. Neuropharmacology, 2024, 257: 110057. doi: 10.1016/j.neuropharm.2024.110057
    [20] DEMAYO M M, HARRIS A D, SONG Y J C, et al. Age-related parietal GABA alterations in children with autism spectrum disorder[J]. Autism Res, 2021, 14(5): 859-872. doi: 10.1002/aur.2487
    [21] MAROTTA R, RISOLEO M C, MESSINA G, et al. The neurochemistry of autism[J]. Brain Sci, 2020, 10(3): 163. doi: 10.3390/brainsci10030163
    [22] KASATKINA L A, TARASENKO A S, KRUPKO O O, et al. Vitamin D deficiency induces the excitation/inhibition brain imbalance and the proinflammatory shift[J]. Int J Biochem Cell Biol, 2020, 119: 105665. doi: 10.1016/j.biocel.2019.105665
    [23] PIZZELLA A, PENNA E, LIU Y, et al. Alterations of synaptic plasticity in Angelman syndrome model mice are rescued by 5-HT7R stimulation[J]. Prog Neurobiol, 2024, 242: 102684. doi: 10.1016/j.pneurobio.2024.102684
    [24] PATRICK R P, AMES B N. Vitamin D hormone regulates serotonin synthesis. Part 1: relevance for autism[J]. Faseb J, 2014, 28(6): 2398-2413. doi: 10.1096/fj.13-246546
    [25] DE MARZIO M, LASKY-SU J, CHU S H, et al. The metabolic role of vitamin D in children's neurodevelopment: a network study[J]. Sci Rep, 2024, 14(1): 16929. doi: 10.1038/s41598-024-67835-8
    [26] APARECIDA NEDEL PERTILE R, KILTSCHEWSKIJ D, GEAGH-AN M, et al. Developmental vitamin D-deficiency increases the expression of microRNAs involved in dopamine neuron development[J]. Brain Res, 2022, 1789: 147953. doi: 10.1016/j.brainres.2022.147953
    [27] DICARLO G E, WALLACE M T. Modeling dopamine dysfunction in autism spectrum disorder: from invertebrates to vertebrates[J]. Neurosci Biobehav Rev, 2022, 133: 104494. doi: 10.1016/j.neubiorev.2021.12.017
    [28] TORDJMAN S, CHARRIER A, KAZATCHKINE M, et al. Natural IgG anti-f (ab')(2) autoantibody activity in children with autism[J]. Biomedicines, 2023, 11(3): 715. doi: 10.3390/biomedicines11030715
    [29] LONG J, DANG H, SU W, et al. Interactions between circulating inflammatory factors and autism spectrum disorder: a bidirectional Mendelian randomization study in European population[J]. Front Immunol, 2024, 15: 1370276. doi: 10.3389/fimmu.2024.1370276
    [30] EL-SHARKAWY A, MALKI A. Vitamin D signaling in inflammation and cancer: molecular mechanisms and therapeutic implications[J]. Molecules, 2020, 25(14): 3219. doi: 10.3390/molecules25143219
    [31] SASSI F, TAMONE C, D'AMELIO P. Vitamin D: nutrient, hormone, and immunomodulator[J]. Nutrients, 2018, 10(11): 1656. doi: 10.3390/nu10111656
    [32] VUILLERMOT S, LUAN W, MEYER U, et al. Vitamin D treatment during pregnancy prevents autism-related phenotypes in a mouse model of maternal immune activation[J]. Mol Autism, 2017, 8: 9. doi: 10.1186/s13229-017-0125-0
    [33] BJØRKLUND G, MEGUID N A, EL-BANA M A, et al. Oxidative stress in autism spectrum disorder[J]. Mol Neurobiol, 2020, 57(5): 2314-2332. doi: 10.1007/s12035-019-01742-2
    [34] ERDOGAN M A, NESIL P, ALTUNTAS I, et al. Amelioration of propionic acid-induced autism spectrum disorder in rats through dapagliflozin: the role of IGF-1/IGFBP-3 and the Nrf2 antioxidant pathway[J]. Neuroscience, 2024, 554: 16-25. doi: 10.1016/j.neuroscience.2024.07.013
    [35] ABDOU H M, SAAD A M, ABD ELKADER H A E, et al. Role of vitamin D(3) in mitigating sodium arsenite-induced neurotoxicity in male rats[J]. Toxicol Res (Camb), 2024, 13(6): tfae203. doi: 10.1093/toxres/tfae203
    [36] DELUCA H F. Vitamin D: historical overview[J]. Vitam Horm, 2016, 100: 1-20.
    [37] SAECHUA C, SARACHANA T, CHONCHAIYA W, et al. Impact of gene polymorphisms involved in the vitamin D metabolic pathway on the susceptibility to and severity of autism spectrum disorder[J]. Sci Rep, 2024, 14(1): 28333. doi: 10.1038/s41598-024-79994-9
    [38] ZHANG Z, LIU J, JIANG G, et al. Vitamin D receptor gene variants and serum vitamin D in childhood autism spectrum disorder[J]. Mol Biol Rep, 2022, 49(10): 9481-9488. doi: 10.1007/s11033-022-07829-9
    [39] JEON S M, SHIN E A. Exploring vitamin D metabolism and function in cancer[J]. Exp Mol Med, 2018, 50(4): 1-14.
    [40] ONG L T C, BOOTH D R, PARNELL G P. Vitamin D and its effects on DNA methylation in development, aging, and disease[J]. Mol Nutr Food Res, 2020, 64(23): e2000437. doi: 10.1002/mnfr.202000437
    [41] SAAD K, ABDEL-RAHMAN A A, ELSEROGY Y M, et al. Vitamin D status in autism spectrum disorders and the efficacy of vitamin D supplementation in autistic children[J]. Nutr Neurosci, 2016, 19(8): 346-351. doi: 10.1179/1476830515Y.0000000019
    [42] MORADI H, SOHRABI M, TAHERI H, et al. Comparison of the effects of perceptual-motor exercises, vitamin D supplementation and the combination of these interventions on decreasing stereotypical behavior in children with autism disorder[J]. Int J Dev Disabil, 2018, 66(2): 122-132.
    [43] PRINCIPI N, ESPOSITO S. Vitamin D deficiency during pregnancy and autism spectrum disorders development[J]. Front Psychiatry, 2019, 10: 987. doi: 10.3389/fphys.2019.00987
    [44] MAZAHERY H, CONLON C A, BECK K L, et al. Inflammation (IL-1β) modifies the effect of vitamin D and Omega-3 long chain polyunsaturated fatty acids on core symptoms of autism spectrum disorder: an exploratory pilot study[J]. Nutrients, 2020, 12(3): 661. doi: 10.3390/nu12030661
    [45] JIA F, SHAN L, WANG B, et al. Fluctuations in clinical symptoms with changes in serum 25(OH) vitamin D levels in autistic children: three cases report[J]. Nutr Neurosci, 2019, 22(12): 863-866. doi: 10.1080/1028415X.2018.1458421
    [46] FENG J, SHAN L, DU L, et al. Clinical improvement following vitamin D3 supplementation in autism spectrum disorder[J]. Nutr Neurosci, 2017, 20(5): 284-290. doi: 10.1080/1028415X.2015.1123847
    [47] LI B, XU Y, ZHANG X, et al. The effect of vitamin D supplementation in treatment of children with autism spectrum disorder: a systematic review and Meta-analysis of randomized controlled trials[J]. Nutr Neurosci, 2022, 25(4): 835-845. doi: 10.1080/1028415X.2020.1815332
    [48] 程爽, 熊振芳, 蔡艺, 等. 维生素D治疗孤独症谱系障碍患儿疗效及安全性的Meta分析[J]. 药物流行病学杂志, 2021, 30(12): 801-805, 826.

    CHENG S, XIONG Z F, CAI Y, et al. Meta-analysis on the efficacy and safety of vitamin D therapy on children with autism spectrum disorder[J]. Chin J Pharmac Epidemiol, 2021, 30(12): 801-805, 826. (in Chinese)
  • 加载中
计量
  • 文章访问数:  83
  • HTML全文浏览量:  43
  • PDF下载量:  17
  • 被引次数: 0
出版历程
  • 收稿日期:  2024-10-18
  • 修回日期:  2025-01-12
  • 网络出版日期:  2025-03-05
  • 刊出日期:  2025-02-25

目录

    /

    返回文章
    返回